Skoči na glavni sadržaj

Stručni rad

Incidence of symptoms of fatigue, pain and sleep disorders in patients with a malignant disease who are actively involved in the rehabilitation process

Ivana Crnković orcid id orcid.org/0000-0002-5973-731X ; University of Applied Health Sciences in Zagreb, Department of Physiotherapy
Ivan Brumini orcid id orcid.org/0000-0002-0275-1751 ; University of Applied Health Sciences Zagreb, Department of Anatomy and Physiology
Aleksandar Racz orcid id orcid.org/0000-0002-3118-2623 ; University of Applied Health Sciences in Zagreb, Department of Public Health and Health Care


Puni tekst: hrvatski pdf 391 Kb

str. 39-39

preuzimanja: 537

citiraj


Sažetak

The incidence of symptoms of chronic fatigue in cancer patients (cancer-related fatigue, CRF) is a significant factor in the assessment of quality of life, and occurs during and after the implementation of oncological treatment. The aim of this study was to investigate the incidence of symptoms of fatigue, pain and sleep disorders in patients with a malignant disease in relation to the involvement in the rehabilitation process and sport activity. The study included 129 people with malignant diseases. We used the EORTC QLQ-C30 questionnaire version 3.0 for self-assessment of quality of life that in subscales examine fatigue, pain and sleeping disorder. Research results confirm that people with malignant diseases who are active participants in the rehabilitation process and active in sports estimate a significantly lower fatigue than those who are not involved in sports. Education, active participation of people with malignant diseases in a rehabilitation process with a strictly individualized approach to inclusion of oncology patients in physical activity are the most important strategies in the battle against the symptoms of fatigue.

Ključne riječi

fatigue; EORTC QLQ; rehabilitation; physical activity

Hrčak ID:

219611

URI

https://hrcak.srce.hr/219611

Datum izdavanja:

17.4.2019.

Podaci na drugim jezicima: hrvatski

Posjeta: 2.011 *